The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.

Phil Gotwals talks about his vision for the future of business development for research.

When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.